A Phase 1 Study to Evaluate the Relative Bioavailability of a VX-828 Tablet Formulation
Status:
COMPLETED
Trial end date:
2025-05-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the relative bioavailability of a VX-828 tablet formulation compared to a suspension and evaluate its safety and tolerability.